
doi: 10.2217/imt.12.83
pmid: 23046227
Biotherapy Center of the First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China and Department of Medicine, Cancer Therapy & Research Center, University of Texas Health Science Center, San Antonio, TX 78229, USA and Robert H Lurie Comprehensive Cancer Center, Department of Medicine – Division of Hematology/Oncology, Northwestern University, Feinberg School of Medicine, 300 E Superior Street‐Tarry 13‐766, Chicago, IL 60611, USA Tel.: +1 312 503 1104 Fax: +1 312 503 0189 bin.zhang@northwestern.edu Opportunities and challenges for anti-CD73 cancer therapy
Neoplasms, Tumor Microenvironment, Animals, Humans, Immunotherapy, 5'-Nucleotidase
Neoplasms, Tumor Microenvironment, Animals, Humans, Immunotherapy, 5'-Nucleotidase
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 18 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
